Skip to content
← Drug library
Drug reference

Lactate

Selected topical ammonium lactate 12%

Inventory umbrella clarified through prescription topical products; other lactate medicines require separate identification and review.

Selected scope
Topical ammonium lactate 12%
Formulations
Prescription cream and lotion
Identity boundary
Not a systemic lactate dosing guide
Essential safety

Verify topical identity before use

Selected 12% ammonium-lactate products are for skin only. Stop for allergy or worsening skin and protect treated areas from sunlight. The inventory umbrella does not supply an IV-fluid regimen.

Warnings and precautions
01

Indications

Verified topical ammonium lactate; inventory slug retained.

Selected clinical identity

This profile selects prescription 12% ammonium-lactate cream/lotion for xerosis and ichthyosis vulgaris; lotion also temporarily relieves associated itching. Public records identify ANDA products. The inventory umbrella does not authorize an IV sodium-lactate or Lactated Ringer’s regimen.

Scope boundary

Confirm active ingredient, concentration, route and package. Other salts, OTC brands and fluid products require their own assessment; clinical interchangeability is not established by sharing the word lactate.

02

Dosage and administration

Apply the selected topical product as directed.

Application

Rub into affected skin twice daily or as prescribed. Shake lotion first. External skin use only; avoid eyes, lips and mucosa. No universal gram maximum or course length is established.

Organ-function boundaries

No kidney, liver or dialysis dose algorithm is supplied. Assess the actual skin condition and tolerability; do not transfer a fluid/electrolyte dosing protocol to these products.

03

Safety

Irritation, allergy and sunlight precautions matter.

Warnings and precautions

Minimize natural/artificial sunlight on treated areas; use protective clothing if exposure is unavoidable. Broken/shaved skin may sting; facial application needs caution. Stop if skin worsens or allergy occurs.

Contraindications

Prior hypersensitivity to a formulation ingredient contraindicates use.

Boxed-warning status

No boxed warning in selected labels. Mouse ultraviolet-exposure findings do not establish a human cancer rate.

Adverse reactions

Burning, stinging, rash, redness, dryness and itching occur; rates vary by formulation and skin diagnosis. Severe or persistent symptoms need assessment.

04

Drug interactions

Review the entire skin-care plan.

Medication review

Selected labels do not provide a systemic interaction algorithm. Discuss other topical treatments and irritation before combining; no validated CYP or separation-time rule is inferred.

05

Use in specific populations

Pediatric wording differs between cream and lotion.

Children and older adults

Cream evidence starts at age two; lotion describes infant/child effectiveness without a numerical minimum. Neither supplies a universal infant gram dose. Older-adult evidence is limited; select cautiously.

Pregnancy and breastfeeding

Controlled pregnancy data are inadequate; use only when clearly needed. Effects on milk lactate are unknown despite lactate’s normal presence in the body; use caution and individual assessment.

Kidney and liver disease

No validated numerical adjustment is established for these topical products. This absence does not establish unrestricted systemic exposure or safety in every clinical setting.

06

Clinical pharmacology

An alpha-hydroxy-acid humectant acts locally.

Mechanism

Supports outer-skin hydration and may reduce corneocyte cohesion; the complete mechanism is uncertain.

Disposition limits

Cadaver-skin studies found approximately 6.1% cream and 5.8% lotion absorption over 68 hours. These are in-vitro observations, not human systemic half-lives or dosing conversions.

07

Monitoring and counseling

Follow skin response and tolerability.

Monitoring

Assess dryness/scaling, itch and irritation. No routine serum-lactate monitoring schedule is established for labeled topical treatment.

Counseling

Keep the route clear: neither swallow nor apply intravaginally/ophthalmically. Protect treated skin from sunlight and stop for allergy or deterioration. Verify product-specific instructions.

08

Product identification

Selected prescription examples; other brands differ.

Representative product identity

Cream 140 g tube: NDC 51672-1301-2. Lotion 225 g bottle: NDC 51672-1300-5. Cream’s other package-panel NDC/size conflict remains unresolved; those examples are omitted.

Dosage forms and strengths

Selected cream/lotion contain 12% lactic acid as ammonium lactate, pH 4.5–5.5. This is not a salt-mass-to-IV conversion.

Storage and handling

Store 20–25°C. Retain product labeling and follow its expiry; no universal after-opening interval is provided.

09

References

Original sources for the clinical and product information.

  1. Sun / DailyMedAmmonium lactate 12% cream · Full prescription label

    PI October 2025; SPL 9 effective August 17, 2026; ANDA075883.

  2. Sun / DailyMedAmmonium lactate 12% lotion · Full prescription label

    PI October 2025; SPL 7 effective July 30, 2026; ANDA076216.

LearnOpen tools